Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin delayed-release versus placebo and active comparator in type 2 diabetes mellitus with renal function ranging from normal to CKD3B
2020-000763-23Phase 3Active
- Sponsor
- Anji Pharma
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Anji Pharma. Primary endpoint: Change in HbA1c from baseline to Week 28. Started Sep 2021; status: active.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2020-000763-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000763-23.